Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.05 | 0.00 | 0.00 |
| FCF Yield | 10.02% | 10.11% | 8.75% | 0.00% |
| EV / EBITDA | 11.69 | 11.58 | 21.06 | 0.00 |
| Quality | ||||
| ROIC | 1.20% | 1.20% | 0.42% | 0.00% |
| Gross Margin | 51.82% | 51.82% | 54.31% | 0.00% |
| Cash Conversion Ratio | 2.74 | 2.74 | 5.98 | 122.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.35% | -1.84% | -3.71% | -5.96% |
| Free Cash Flow Growth | 0.00% | 15.77% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -0.87 | -0.87 | 0.25 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.59 | 0.59 | 0.59 | 0.00 |
| Cash Conversion Cycle | 151.72 | 128.67 | 127.44 | 0.00 |